Immunotherapies are a groundbreaking cancer treatment curing patients with a success impossible five years ago.
There are some challenges:
Only work in 20-30% of patients.
Unique spectrum of side effects and fatal toxicities may occur.
High per-patient price and costly to develop
5 Parvis Alan Turing, 75013